BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 8919227)

  • 1. Correlates of vascular access and nonvascular access-related hospitalizations in hemodialysis patients.
    Ifudu O; Mayers JD; Cohen LS; Paul H; Brezsnyak WF; Avram MM; Herman AI; Friedman EA
    Am J Nephrol; 1996; 16(2):118-23. PubMed ID: 8919227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hemodialysis vascular access morbidity in the United States.
    Feldman HI; Held PJ; Hutchinson JT; Stoiber E; Hartigan MF; Berlin JA
    Kidney Int; 1993 May; 43(5):1091-6. PubMed ID: 8510387
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determinants of type of initial hemodialysis vascular access.
    Ifudu O; Macey LJ; Homel P; Hyppolite JC; Hong J; Sumrani N; Distant D; Sommer BG; Friedman EA
    Am J Nephrol; 1997; 17(5):425-7. PubMed ID: 9382160
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Analysis of the survival of permanent vascular access ports].
    Rodríguez JA; Ferrer E; Olmos A; Codina S; Borrellas J; Piera L
    Nefrologia; 2001; 21(3):260-73. PubMed ID: 11471307
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vascular access outcomes and medication use: a USRDS study.
    Yevzlin AS; Conley EL; Sanchez RJ; Young HN; Becker BN
    Semin Dial; 2006; 19(6):535-9. PubMed ID: 17150056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hospitalization risks related to vascular access type among incident US hemodialysis patients.
    Ng LJ; Chen F; Pisoni RL; Krishnan M; Mapes D; Keen M; Bradbury BD
    Nephrol Dial Transplant; 2011 Nov; 26(11):3659-66. PubMed ID: 21372255
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hemodialysis access-related survival and morbidity in an elderly population in South West Thames, UK.
    Ekbal NJ; Swift PA; Chalisey A; Steele M; Makanjuola D; Chemla E
    Hemodial Int; 2008 Oct; 12 Suppl 2():S15-9. PubMed ID: 18837763
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sex Differences in Hospitalizations with Maintenance Hemodialysis.
    Adams SV; Rivara M; Streja E; Cheung AK; Arah OA; Kalantar-Zadeh K; Mehrotra R
    J Am Soc Nephrol; 2017 Sep; 28(9):2721-2728. PubMed ID: 28432127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The Veneto Region's Registry of Dialysis and Transplantation: 2006-2007 report].
    Antonucci F; Camerin E; Feriani M; Nordio M; Piccoli A; Rossi B; Tessitore N
    G Ital Nefrol; 2009; 26 Suppl 48():S5-56. PubMed ID: 19927265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hemodialysis vascular access dysfunction: from clinical stenosis to specific cell types.
    Roy-Chaudhury P; Munda R; Edwards J; Kelly BS
    J Nephrol; 2003; 16(2):277. PubMed ID: 12768077
    [No Abstract]   [Full Text] [Related]  

  • 11. Survival of vascular access during daily and three times a week hemodialysis.
    Quintaliani G; Buoncristiani U; Fagugli R; Kuluiranu H; Ciao G; Rondini L; Lowenthal DT; Reboldi G
    Clin Nephrol; 2000 May; 53(5):372-7. PubMed ID: 11305810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Associates of mortality and hospitalization in hemodialysis: potentially actionable laboratory variables and vascular access.
    Lacson E; Wang W; Hakim RM; Teng M; Lazarus JM
    Am J Kidney Dis; 2009 Jan; 53(1):79-90. PubMed ID: 18930570
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Infection-related hospitalization of hemodialysis patients].
    Vaiciūniene R; Kuzminskis V; Petruliene K; Dvaranauskaite L
    Medicina (Kaunas); 2007; 43 Suppl 1():65-71. PubMed ID: 17551279
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Fistulae or catheter for elderly who start hemodialysis without permanent vascular access?].
    García Cortés MJ; Viedma G; Sánchez Perales MC; Borrego FJ; Borrego J; Pérez del Barrio P; Gil Cunquero JM; Liébana A; Pérez Bañasco V
    Nefrologia; 2005; 25(3):307-14. PubMed ID: 16053012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Hospitalizations of hemodialysis patients (data of Kaunas University of Medicine Hospital in 2001)].
    Vaiciūniene R; Kuzminskis V; Kadisaite I
    Medicina (Kaunas); 2003; 39 Suppl 1():109-14. PubMed ID: 12761431
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Updates in clinical hemodialysis: vascular accessess and elderly patients].
    López Gómez JM
    Nefrologia; 2008; 28 Suppl 5():67-70. PubMed ID: 18847423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of recombinant human erythropoietin on hospitalization of hemodialysis patients.
    Churchill DN; Muirhead N; Goldstein M; Posen G; Fay W; Beecroft ML; Gorman J; Taylor DW
    Clin Nephrol; 1995 Mar; 43(3):184-8. PubMed ID: 7774076
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lipoprotein(a) and vascular access survival in patients on chronic hemodialysis.
    Hernández E; Praga M; Alamo C; Araque A; Morales JM; Alcazar JM; Ruilope LM; Rodicio JL
    Nephron; 1996; 72(2):145-9. PubMed ID: 8684517
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal replacement in end-stage renal disease patients over 75 years old.
    Létourneau I; Ouimet D; Dumont M; Pichette V; Leblanc M
    Am J Nephrol; 2003; 23(2):71-7. PubMed ID: 12481144
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Canadian Hemodialysis Morbidity Study.
    Churchill DN; Taylor DW; Cook RJ; LaPlante P; Barre P; Cartier P; Fay WP; Goldstein MB; Jindal K; Mandin H
    Am J Kidney Dis; 1992 Mar; 19(3):214-34. PubMed ID: 1553966
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.